Deposition and biokinetics of inhaled nanoparticles
Open accessThe DOI matches its Crossref record; 114 of the 115 references it cites were found in a registry or an index.
Abstract
Particle biokinetics is important in hazard identification and characterization of inhaled particles. Such studies intend to convert external to internal exposure or biologically effective dose, and may help to set limits in that way. Here we focus on the biokinetics of inhaled nanometer sized particles in comparison to micrometer sized ones.The presented approach ranges from inhaled particle deposition probability and retention in the respiratory tract to biokinetics and clearance of particles out of the respiratory tract. Particle transport into the blood circulation (translocation), towards secondary target organs and tissues (accumulation), and out of the body (clearance) is considered. The macroscopically assessed amount of particles in the respiratory tract and secondary target organs provides dose estimates for toxicological studies on the level of the whole organism. Complementary, microscopic analyses at the individual particle level provide detailed information about which cells and subcellular components are the target of inhaled particles. These studies contribute to shed light on mechanisms and modes of action eventually leading to adverse health effects by inhaled nanoparticles.We review current methods for macroscopic and microscopic analyses of particle deposition, retention and clearance. Existing macroscopic knowledge on particle biokinetics and microscopic views on particle organ interactions are discussed comparing nanometer and micrometer sized particles. We emphasize the importance for quantitative analyses and the use of particle doses derived from real world exposures.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Concept of quantitative nanoparticle biokinetics. Nanoparticles (NP) are administered at time t = 0. From this time point on, the entire urinary and fecal excretions are collected separately. Animals are euthanized at times t1, t2, t3, etc., and organs and tissues of interest as well as the entire remaining carcass are sampled (100% balanced sampling). Samples require special preparation before chemical analysis, e.g. by inductive-coupled-plasma mass spectroscopy (ICP-MS). When nanoparticles are radio-labeled, samples will be analyzed directly, without any further preparation. Reprinted with permission from [21].](https://figures.cochat.ai/paper-figures/ee788260efb2475485b7a3373db0cd2b/deposition-and-biokinetics-of-inhaled-nanoparticles-figure-1.jpg)
![Figure 2 Micrographs of horse trachea fixed by immersion in non-polar fixative (A, B). Note that the lung lining layer (aqueous phase [asterix] and surfactant film at the air liquid interface [arrow]), has been preserved with this fixation technique. EP = epithelium, CI = cilia. Bars: (A) = 2 μm, (B) = 0.2 μm. Reprinted with permission from [21].](https://figures.cochat.ai/paper-figures/13b7448107bc43cfab649db639f065c4/deposition-and-biokinetics-of-inhaled-nanoparticles-figure-2.jpg)

![Figure 4 Elemental microanalysis of a particle in lung tissue by electron spectroscopic imaging (ESI, three window method), demonstrating that the nanoparticles (arrows) consists of titanium, adapted from [21]. The first image (A), taken at 0 eV, shows the structural details; it is slightly shifted as compared to the images used for elemental microanalyses (B-D). For elemental microanalysis, three images are taken: two below the element-specific edge in order to extrapolate a background image, at ΔE = 390eV (not shown) and ΔE = 440eV (B), respectively, and one image within the maximum of the element specific signal at ΔE = 464eV (L2,3 edge of titanium) (C). The net titanium signal (D) is calculated by subtraction of the extrapolated background image from the titanium specific signal. ESI images have reversed contrast as solely inelastically scattered electrons are used with an energy loss producing a dark field image. Hence, the obtained image reflects the titanium distribution in white pixels. Bar: 500 nm.](https://figures.cochat.ai/paper-figures/d771db9f64944c1baa1ac78574e99548/deposition-and-biokinetics-of-inhaled-nanoparticles-figure-4.jpg)
![Figure 5 Multistage tissue sampling design for EFTEM analysis of nanoparticles, adapted from [21]. Stage 1 - Lung slices: exhaustive cutting of agar embedded lung lobes (with random start) into equally thick slices [38], followed by systematic sampling of slices, e.g. every second (with random start) and Epon embedding. Stage 2 - Tissue blocks and ultrathin sections: systematic sampling (with random start) of tissue blocks from lung slices using a point counting test system and cutting of ultrathin (≤ 50 nm) sections, which are placed on 600-mesh hexagonal copper grids and stained with lead citrate and uranyl acetate. Stage 3 - Quadrats on ultrathin sections: generation of a virtual field, completely contained within the ultrathin section, at 80× magnification. Field subdivision into a predetermined number of uniform quadrats and systematic subsampling of quadrats thereof (marked in grey). Stage 4 - Fields for nanoparticle analysis: Subsampling of a group of seven adjacent fields, delimited by the hexagonal TEM grid bars, within each quadrat at 6300× magnification, using a point counting test system. Tissue analysis within these hexagonal fields for (i) the presence of particles with matching nanoparticle characteristics and (ii) particle localization within the compartments of interest. Stages 3 and 4 can equally be applied on ultrathin sections of cell pellets. Alternative to stages 3 and 4 - Fields for nanoparticle analysis are sampled by picking a random hexagonal field on the ultrathin section as starting point at 80× magnification. From there on systematic tissue analysis in horizontal and vertical direction, using the automated goniometer of the microscope.](https://figures.cochat.ai/paper-figures/79380803d2db477d8c788e4be496c2ff/deposition-and-biokinetics-of-inhaled-nanoparticles-figure-5.jpg)
![Figure 6 The respiratory tract (A) and particle deposition in a normal adult mouth breathing male human subject at rest, as a function of particle size (B). Data of bronchi are the sum of the deposition in bronchi and bronchioles. Adapted from [105] and [39] and reprinted with permission from [21].](https://figures.cochat.ai/paper-figures/c62fd67bcc274d018f65e1fb61af1b13/deposition-and-biokinetics-of-inhaled-nanoparticles-figure-6.jpg)
![Figure 7 Components of the inner surface of the lungs (A); particle deposition and immediate wetting (B) and complete displacement (C) of the deposited particle (white sphere) into the lung lining layer by surfactant. Reprinted with permission from [21].](https://figures.cochat.ai/paper-figures/85ff1ed521b549e59ce1dbbdff93e195/deposition-and-biokinetics-of-inhaled-nanoparticles-figure-7.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Lung clearance of particulate matter depends on the site of deposition as well as material characteristics including solubility and bioreactivity [9, 10].”
From Effects from a 90-day inhalation toxicity study with cerium oxide and barium sulfate nanoparticles in rats (2017) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In contrast, only 20% of 20-nm-sized NPs and about 30% of 70-nm-sized NP deposited during inhalation or instillation can be lavaged – see Fig. 2 [54–59].”
From Particle toxicology and health - where are we? (2019) · cites this paper as [57]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Nano-sized particles (< 100 nm) deposit in the whole respiratory tract, ending up in the alveolar region where its deposition is dominated by processes of diffusion [7–9].”
From Effects from a 90-day inhalation toxicity study with cerium oxide and barium sulfate nanoparticles in rats (2017) · cites this paper as [9]
The cited source says what the claim attributes to it.
In the citing paper
“In the alveolar space the most relevant route of particle clearance is phagocytosis by alveolar macrophages and subsequent elimination primarily via the mucociliary escalator or secondarily via the lymphatic system [9, 10].”
From Effects from a 90-day inhalation toxicity study with cerium oxide and barium sulfate nanoparticles in rats (2017) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles
Oberdörster, G., Oberdörster, E., & Oberdörster, J. (2005) · Environmental Health Perspectives · doi:10.1289/ehp.7339 · Cited by 7,891 · cited 1×
“Cardiovascular effects observed in these studies triggered the discussion on increased transport of inhaled ultrafine particles from the epithelial surface towards the blood circulation and subsequently to target organs, like the heart, liver and brain, eventually adversely affecting the functions of these organs [69].”
BackgroundCedervall, T., Lynch, I., Lindman, S., Berggård, T., Thulin, E., Nilsson, H., Dawson, K. A., & Linse, S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608582104 · Cited by 3,281 · cited 1×
“Microparticles would be excluded from this transport because of their larger size [70-72].”
BackgroundThe unbiased estimation of number and sizes of arbitrary particles using the disector
Sterio, D. C. (1984) · Journal of Microscopy · doi:10.1111/j.1365-2818.1984.tb02501.x · Cited by 2,519 · cited 1×
“[ 35-37 ]). We have implemented this technique to count micrometer sized particles and airway macrophages in lungs by light microscopy (e.g.”
MethodPolymer conjugates as anticancer nanomedicines
Duncan, R. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1958 · Cited by 1,962 · cited 1×
“as diagnostic tools or therapeutics in medicine [6,7] health risk assessment is necessary.”
BackgroundHuman Respiratory Tract Model for Radiological Protection
Icrp (1994) · Annals of the ICRP · Cited by 1,767
Protein-nanoparticle interactions
Lynch, I., & Dawson, K. A. (2008) · Nano Today · doi:10.1016/s1748-0132(08)70014-8 · Cited by 1,727
Laden, F., Schwartz, J., Speizer, F. E., & Dockery, D. W. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200503-443oc · Cited by 1,416 · cited 1×
“[ 1-5 ]). Also, for nanoparticles with anticipated beneficial use, e.g.”
BackgroundGeiser, M., Rothen-Rutishauser, B., Kapp, N., Schürch, S., Kreyling, W., Schulz, H., Semmler, M., Hof, V. I., Heyder, J., & Gehr, P. (2005) · Environmental Health Perspectives · doi:10.1289/ehp.8006 · Cited by 1,407
Self-citationLaden, F., Neas, L. M., Dockery, D. W., & Schwartz, J. (2000) · Environmental Health Perspectives · doi:10.1289/ehp.00108941 · Cited by 1,296 · cited 1×
“[ 1-5 ]). Also, for nanoparticles with anticipated beneficial use, e.g.”
BackgroundUnbiased Stereology: Three-Dimensional Measurement in Microscopy
Howard, C. V., & Reed, M. (1998) · Cited by 1,149
Research works printed but not linked: 3
- Weibel ER Otis AB Morphometric and stereological methods in respiratory physiology including fixation techniques Techniques in the life sciences 1984 Ireland: Elsevier Scientific Publishers 1 35
- Semmler-Behnke M Fertsch S Schmid O Wenk A Kreyling WG Uptake of 1.4 mm versus 18 mm gold particles by secondary target organs is size dependent in control and pregnants rats after intertracheal or intravenoiz application Euro Nanoforum - Nanotechnology in Industrial Applications 2007 102 104 http://www.euronanoforum2007.de/download/Proceedings%20ENF2007.pdf
- Kuempel ED Tran CL Castranova V Bailer AJ Lung dosimetry and risk assessment of nanoparticles: evaluating and extending current models in rats and humans Inhal Toxicol 2006 18 717 724 10.1080/08958370600747887 16774860 · DOI
Cited by
Plastic and Human Health: A Micro Issue?
Wright, S. L., & Kelly, F. J. (2017) · Environmental Science & Technology · doi:10.1021/acs.est.7b00423 · Cited by 3,413
The Effect of Nanoparticle Size on In Vivo Pharmacokinetics and Cellular Interaction
Hoshyar, N., Gray, S., Han, H., & Bao, G. (2016) · Nanomedicine · doi:10.2217/nnm.16.5 · Cited by 1,990
Titanium dioxide nanoparticles: a review of current toxicological data
Shi, H., Magaye, R., Castranova, V., & Zhao, J. (2013) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-10-15 · Cited by 1,498
“Geiser and Kreyling [91] in their review reported that NPs including TiO2 NPs in the size range of 5–100 nm could be translocated across the air-blood-barrier.”
BackgroundUnderstanding nanoparticle endocytosis to improve targeting strategies in nanomedicine
Sousa de Almeida, M., Susnik, E., Drasler, B., Taladriz-Blanco, P., Petri-Fink, A., & Rothen-Rutishauser, B. (2021) · Chemical Society Reviews · doi:10.1039/d0cs01127d · Cited by 1,079
(2014) · doi:10.1007/s11356-014-3696-8 · Cited by 946
“Other studies have shown that ultrafine particles may become blood-borne and translocate to other tissues such as the liver, kidneys and brain (Geiser and Kreyling 1999; Oberdörster et al. 2005), while experiments to animals have shown translocation of inhaled ultrafine particles to the brain (Tjalve and Henriksson 19…”
Background
Metadata
- Authors
- Geiser, M., & Kreyling, W. G.
- Affiliations
- University of Bern (CH)
- Helmholtz Munich (DE)
- Corresponding author
- Geiser, Marianne
- Venue
- Particle and Fibre Toxicology
- Published
- 2010
- Volume
- 7
- Issue
- 1
- Pages
- 2
- ISSN
- 1743-8977 (ISSN-L)
- PMC
- PMC2826283
- OpenAlex
- W2020623049
- Cited by
- 747
- References
- 111
- Citations by year
- 2026: 44 · 2025: 37 · 2024: 44 · 2023: 36 · 2022: 39 · 2021: 56 · 2020: 51 · 2019: 50 · 2018: 40 · 2017: 57 · 2016: 48 · 2015: 52 · 2014: 54 · 2013: 45 · 2012: 48
- FWCI
- 7.44
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Particle and Fibre Toxicology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- BORIS (University Library Bern) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Site cant be reached (submittedVersion, cc-by)
- Open Access CRIS of the University of Bern
- Funders
- National Science Foundation (310030)
- Deutsche Forschungsgemeinschaft (SPP1313)
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (105419, 120763, 3200B0, 310030)
- National Institutes of Health
- National Heart, Lung, and Blood Institute (HL 070542, R01HL070542)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
- Physical Sciences › Materials Science › Materials Chemistry › Nanoparticles: synthesis and applications
- Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Air Quality and Health Impacts
- Keywords
- inhaled nanoparticles, particle deposition, particle clearance, dose estimation, subcellular targeting, exposure assessment, hazard characterization
- MeSH terms
- Air Pollutants, Animals, Animals, Laboratory, Electron Probe Microanalysis, Lung, Metabolic Clearance Rate, Particle Size, Respiratory System, Inhalation Exposure, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Deposition and biokinetics of inhaled nanoparticles. https://app.cochat.ai/papers/10.1186/1743-8977-7-2
- The paper
- Geiser, M., & Kreyling, W. G. (2010). Deposition and biokinetics of inhaled nanoparticles. Particle and Fibre Toxicology. https://doi.org/10.1186/1743-8977-7-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.